Sanja Dacic1, Daniel Shenker2, Mary Redman3
1Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Machine learning models accurately assess pathologic response (PR) in non-small cell lung cancer (NSCLC) after neoadjuvant therapy, showing high agreement with pathologists and similar survival outcomes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: